Journal Article Summary
The article investigates the use of thiazide diuretics, particularly hydrochlorothiazide, in preventing calcium-containing kidney stones (nephrolithiasis). This topic is significant because kidney stones can cause severe pain and complications, and thiazide diuretics have been shown in previous studies to help reduce the recurrence of these stones. However, the authors note a shift in prescribing practices since the 1980s, where lower doses of hydrochlorothiazide are now commonly used for hypertension, which may not be effective for stone prevention.
The study analyzed medical records of 107 patients who had been prescribed thiazide diuretics for at least six months to prevent kidney stones. Among these patients, only 35% were prescribed the higher, evidence-based dose of 50 mg/day of hydrochlorothiazide, which has been shown to reduce stone recurrence in clinical trials. The majority received lower doses (25 mg or 12.5 mg), which have not been proven effective for this purpose. Additionally, a small subset of patients showed a trend toward decreased urinary calcium excretion when the dose was increased, suggesting that higher doses may be more effective.
The authors acknowledge several limitations in their study, including the small sample size for assessing dose-response effects and the lack of long-term follow-up. They emphasize the importance of discussing medication options with healthcare professionals, particularly regarding the appropriate dosing of thiazide diuretics for kidney stone prevention. Patients should be aware that using lower doses may not provide the same benefits as higher doses, and further research is needed to determine the most effective treatment strategies for reducing kidney stone recurrence safely.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Vigen Rebecca, Weideman Rick A., Reilly Robert F.. Thiazides diuretics in the treatment of nephrolithiasis: are we using them in an evidence-based fashion?. International urology and nephrology 2010. DOI: 10.1007/s11255-010-9824-6. PMID: 20737209. PMCID: PMC3229098.
Featured Pill Pals Product
Indapamide 1.25 mg Tablets --- Generic For Lozol --- ANI Pharma
Indapamide 1.25 mg Tablets — Generic For Lozol — ANI Pharma is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
